Immune Responses to AAV-Vectors, the Glybera Example from Bench to Bedside

Alipogene tiparvovec (Glybera(®)) is an adeno-associated virus serotype 1 (AAV1)-based gene therapy that has been developed for the treatment of patients with lipoprotein lipase (LPL) deficiency. Alipogene tiparvovec contains the human LPL naturally occurring gene variant LPL(S447X) in a non-replica...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Valerie, Petry, Harald, Salmon, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939780/
https://www.ncbi.nlm.nih.gov/pubmed/24624131
http://dx.doi.org/10.3389/fimmu.2014.00082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939780/
https://www.ncbi.nlm.nih.gov/pubmed/24624131
http://dx.doi.org/10.3389/fimmu.2014.00082

Ejemplares similares